Loading chart…
PRE-MARKET
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever.
Valiant Laboratories Limited (VALIANTLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The VALIANTLAB share price is ₹111.51 (-3.95% today), with a market capitalisation of ₹6B and a price-to-earnings (P/E) ratio of 39.7. MarketRipple tracks the VALIANTLAB investment thesis, the ripple-chain impact of market events on Valiant Laboratories Limited, and the Healthcare sector outlook.
Open
₹111.51
High
₹111.51
Low
₹111.51
Prev. Close
₹116.10
52W High
₹141.38
52W Low
₹49.51
Day range
₹111.51–₹111.51
52-week range
₹49.51–₹141.38
Volume
4K
P/E
39.7
ROE
-1.1%
D/E
0.15
Margin
5.2%
Valiant Laboratories Limited (NSE: VALIANTLAB) is currently trading at ₹111.51 (-3.95%).
Valiant Laboratories Limited's market capitalization is ₹6B.
Valiant Laboratories Limited's price-to-earnings (P/E) ratio is 39.7.
Valiant Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).